Skip to main content
OpenTrials
Completed

NCT Number: NCT00714922

Comparison of Photorefractive Keratectomy (PRK) and Sub-Bowman's Keratomileusis (SBK)

The objective of the study is to compare clinical outcomes from PRK and SBK using FDA-approved laser technology in the same patient

Completed

Looking for future studies?

Notify Me

Key information

Age range

21 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Utah, John Moran Eye Center

Salt Lake City, Utah, 84106, United States

About this study

Patients undergoing bilateral laser refractive surgery on the same day will be randomly assigned to have one eye treated with PRK and the fellow eye treated with SBK.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients deemed to be suitable candidates for bilateral LASIK surgery

Exclusion criteria

  • Patients who desire monovision correction rather than bilateral distance correction

Treatment and study plan

PRK

Procedure

Laser refractive surgery

SBK

Procedure

Laser refractive surgery

Primary outcomes

  1. Visual acuity

    Time frame: 6 months

Secondary outcomes

  1. Manifest refraction

    Time frame: 6 months

  2. Wavefront aberration value

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

University of Utah

Other

Registry information

Official study title

Comparison of Photorefractive Keratectomy (PRK) and Sub-Bowman's Keratomileusis (SBK): Assessment of Visual Function and Patient Satisfaction

Important dates

Study start
2007
Primary completion
2010
Study completion
2010
First posted
Jul 14, 2008
Registry last updated
Sep 16, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.